A Study of Crofelemer to Treat Diarrhea Irritable Bowel Syndrome

Completed · Phase 2 · Has a placebo group

Conditions studied: Irritable Bowel Syndrome, Colonic Diseases, Diarrhea, Gastrointestinal Disease

In brief

This study is designed to evaluate the safety and effectiveness of an investigational drug, TRN-002 (crofelemer) to relieve the symptoms of diarrhea-predominant irritable bowel syndrome (IBS).

Key facts

Study ID
NCT00101725
Run by
Bausch Health Americas, Inc.
People needed
245
Starts
2004-12-01
Expected to finish
2005-11-01
Last updated by the study team
2019-11-25

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.